Yanjun Shen

464 total citations
16 papers, 362 citations indexed

About

Yanjun Shen is a scholar working on Hepatology, Oncology and Cancer Research. According to data from OpenAlex, Yanjun Shen has authored 16 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Yanjun Shen's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer, Lipids, and Metabolism (5 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Yanjun Shen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer, Lipids, and Metabolism (5 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Yanjun Shen collaborates with scholars based in China and United States. Yanjun Shen's co-authors include Wendong Li, Jinglong Chen, Yun Sun, Huige Wang, Xiaoyan Ding, Ying Teng, Wei Sun, Wei Li, Weidong Sun and Xiaodi Guo and has published in prestigious journals such as Cancer, Annals of Oncology and Clinica Chimica Acta.

In The Last Decade

Yanjun Shen

15 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanjun Shen China 10 148 93 85 83 80 16 362
Guowen Yin China 11 136 0.9× 96 1.0× 47 0.6× 77 0.9× 61 0.8× 25 348
Kuo‐Liang Wei Taiwan 12 155 1.0× 118 1.3× 84 1.0× 182 2.2× 60 0.8× 34 438
Haizhou Lou China 10 119 0.8× 121 1.3× 66 0.8× 88 1.1× 107 1.3× 21 379
Bénédicte Delire Belgium 8 148 1.0× 178 1.9× 54 0.6× 149 1.8× 66 0.8× 19 443
I. Sordelli Italy 7 205 1.4× 144 1.5× 139 1.6× 171 2.1× 56 0.7× 13 551
Yuko Kita Japan 12 100 0.7× 121 1.3× 77 0.9× 76 0.9× 71 0.9× 21 382
Silvia Lucano‐Landeros Mexico 9 98 0.7× 135 1.5× 56 0.7× 135 1.6× 36 0.5× 13 458
Akemi Tsutsui Japan 12 213 1.4× 125 1.3× 121 1.4× 239 2.9× 55 0.7× 27 574
Hong-Chuan Zhao China 9 53 0.4× 118 1.3× 71 0.8× 96 1.2× 60 0.8× 14 301
Tomohiko Ohashi Japan 14 152 1.0× 94 1.0× 159 1.9× 314 3.8× 82 1.0× 38 612

Countries citing papers authored by Yanjun Shen

Since Specialization
Citations

This map shows the geographic impact of Yanjun Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjun Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjun Shen more than expected).

Fields of papers citing papers by Yanjun Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanjun Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjun Shen. The network helps show where Yanjun Shen may publish in the future.

Co-authorship network of co-authors of Yanjun Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yanjun Shen. A scholar is included among the top collaborators of Yanjun Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanjun Shen. Yanjun Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Shen, Yanjun, et al.. (2022). The Prognostic Role of Circulating FPR Before Operation in Patients with BCLC A-C Hepatocellular Carcinoma: A Retrospective Cohort Study. Journal of Hepatocellular Carcinoma. Volume 9. 467–476. 3 indexed citations
2.
Ding, Xiaoyan, Guangxin Li, Wei Sun, et al.. (2022). Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting—A Multi-Center Observational Study. Frontiers in Oncology. 12. 907055–907055. 11 indexed citations
3.
Li, Wendong, Xiaoyan Ding, Wei Sun, et al.. (2022). CT-guided percutaneous chemical ablation combined with radiofrequency ablation for hepatocellular carcinomas in high-risk locations: lobaplatin vs. ethanol.. PubMed. 14(9). 6726–6736.
4.
5.
6.
Wang, Huige, et al.. (2020). Prognostic significance of preoperative circulating FAR and FCI scores in patients with ovarian cancer. Clinica Chimica Acta. 509. 252–257. 1 indexed citations
7.
8.
9.
Shen, Yanjun, Huige Wang, Wendong Li, & Jinglong Chen. (2019). Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA. Journal of Clinical Laboratory Analysis. 33(9). e22999–e22999. 28 indexed citations
10.
Shen, Yanjun, Huige Wang, Xiangmei Chen, Wendong Li, & Jinglong Chen. (2019). <p>Prognostic significance of lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization and radiofrequency ablation</p>. OncoTargets and Therapy. Volume 12. 7129–7137. 23 indexed citations
11.
Yang, Horng-Ren, Yan Xiong, Jie Chen, & Yanjun Shen. (2019). Study of mesh infection management following inguinal hernioplasty with an analysis of risk factors: a 10-year experience. Hernia. 24(2). 301–305. 16 indexed citations
12.
Liu, Chang, Yanjun Shen, Yanran Zhao, et al.. (2018). Pedunculoside, a novel triterpene saponin extracted from Ilex rotunda, ameliorates high-fat diet induced hyperlipidemia in rats. Biomedicine & Pharmacotherapy. 101. 608–616. 61 indexed citations
13.
Zhang, Yaqi, Hao Yang, Weidong Sun, et al.. (2017). Ethanol extract of Ilex hainanensis Merr. exhibits anti-melanoma activity by induction of G1/S cell-cycle arrest and apoptosis. Chinese Journal of Integrative Medicine. 24(1). 47–55. 9 indexed citations
14.
Sun, Wei, Xiaoyan Ding, Jinglong Chen, et al.. (2017). [The combination of percutaneous iohexol-ethanol injection with radiofrequency ablation for the treatment of primary liver cancer in high-risk locations].. PubMed. 39(9). 695–700. 1 indexed citations
15.
Yang, Hao, Juan Wang, Jinhong Fan, et al.. (2016). Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth. Toxicology and Applied Pharmacology. 315. 90–101. 56 indexed citations
16.
Liu, Chang, Yi Huang, Yanjun Shen, et al.. (2016). A novel pentacyclic triterpenoid, Ilexgenin A, shows reduction of atherosclerosis in apolipoprotein E deficient mice. International Immunopharmacology. 40. 115–124. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guowen Yin Breakdown of academic impact, for papers by Kuo‐Liang Wei Breakdown of academic impact, for papers by Haizhou Lou Breakdown of academic impact, for papers by Bénédicte Delire Breakdown of academic impact, for papers by I. Sordelli Breakdown of academic impact, for papers by Yuko Kita Breakdown of academic impact, for papers by Silvia Lucano‐Landeros Breakdown of academic impact, for papers by Akemi Tsutsui Breakdown of academic impact, for papers by Hong-Chuan Zhao Breakdown of academic impact, for papers by Tomohiko Ohashi
Rankless by CCL
2026